- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer in New Zealand
Total 3105 results
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Adenocarcinoma AJCC v7 | Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Prostate Adenocarcinoma With Neuroendocrine...United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Ardeshir RastinehadPhilips HealthcareRecruitingProstate Cancer | Prostate Disease | Elevated Prostate Specific Antigen | Family History of Prostate Cancer | Positive Digital Rectal ExamUnited States
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
Tyme, IncCompletedProstate Cancer | Rising Prostate Specific Antigen (PSA)United States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Carolina Research Professionals, LLCBayerCompleted
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount SinaiActive, not recruitingLow Risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
CS Diagnostics GmbHAix ScientificsTerminatedProstate Cancer Patients Treated by RadiotherapyGermany
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
Nuvation Bio Inc.RecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Breast Carcinoma | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Cancer of the Ovary | Pancreas Cancer | Triple-negative Breast Cancer | Cancer of Pancreas | Pancreas Neoplasm | Prostate Neoplasm | Cancer... and other conditionsUnited States, Australia
-
University of Medicine and Dentistry of New JerseyUnited States Department of DefenseWithdrawnProstate CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Ashutosh Kumar TewariOncovir, Inc.RecruitingProstate Cancer Patients on Active SurveillanceUnited States
-
Catherine SpinaArcus Biosciences, Inc.RecruitingOligometastatic Prostate CancerUnited States
-
Eli Lilly and CompanyCompleted
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Genta IncorporatedUnknownProstate CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Sapience TherapeuticsRecruitingBreast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma RecurrentUnited States, United Kingdom
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCActive, not recruitingCastration-resistant Prostate CancerUnited States
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Cadila PharnmaceuticalsTerminatedHormone Refractory Prostate CancerIndia
-
Philips HealthcareWithdrawnProstate CancerUnited States
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Boston Scientific CorporationSuspendedCancer | ProstateUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
BayerCompletedBone Metastases | Castration-Resistant Prostate CancerUnited States, France
-
Celgene CorporationPrologue Research InternationalTerminated
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
PROCEPT BioRoboticsRecruitingLocalized Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Howard University; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Janssen Research & Development, LLCRecruitingAdvanced Prostate CancerFrance, United States
-
Steba Biotech S.A.Active, not recruitingLocalized Prostate CancerUnited States
-
Xanthus Pharmaceuticals, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Completed